CITY
APHP240605
Phase 1 other active
Quick answer
CITY for Cutaneous T-cell lymphomas (CTCL) is a Phase 1 program (other) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Cutaneous T-cell lymphomas (CTCL)
- Phase
- Phase 1
- Modality
- other
- Status
- active